News · 26 weeks32-40%
2025-12-142026-06-07
Mix1390d
- SEC Filings7(54%)
- Other5(38%)
- Earnings1(8%)
Latest news
25 items- SECSEC Form 6-K filed by Aurora Cannabis Inc.6-K - AURORA CANNABIS INC (0001683541) (Filer)
- PRAurora Cannabis to Host Fourth Quarter and Fiscal Year 2026 Investor Conference Call and File Related Year End InformationNASDAQ | TSX: ACBEDMONTON, AB, May 28, 2026 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its fourth quarter and fiscal year 2026 on Thursday, June 11, 2026 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the fourth quarter and fiscal year 2026 before the opening of markets that same day. Conference Call DetailsDATE:Thursday, June 11, 2026TIME:8:00 a.m. Eastern Time | 6:00 a.m. Mountain TimeWEBCAST:
- SECSEC Form 6-K filed by Aurora Cannabis Inc.6-K - AURORA CANNABIS INC (0001683541) (Filer)
- PREurope's Cannabis Boom Is Accelerating as Billions Flow into Licensed MarketsNEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - Europe's licensed cannabis industry is starting to look like one of the most exciting growth stories in the global cannabis market. What was once a fragmented, slow-moving sector is now gaining serious momentum as more countries open up medical cannabis programs, expand patient access, and create clearer licensing frameworks for producers and distributors. Germany continues to lead the charge after its cannabis reforms, but countries like the UK, Portugal, Italy, France, Switzerland, and the Czech Republic are also becoming major pieces of the puzzle. Investors and operators are paying close attention because
- SECSEC Form 6-K filed by Aurora Cannabis Inc.6-K - AURORA CANNABIS INC (0001683541) (Filer)
- PRAurora Granted Plant Breeders' Rights, Strengthening Leadership in Cannabis ScienceNASDAQ | TSX: ACBCanadian grant protects Aurora‑developed genetics bred through the company's advanced research and breeding programEDMONTON, AB, May 14, 2026 /CNW/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, announced today it has been granted Plant Breeders' Rights in Canada for two proprietary cannabis cultivars developed through its world-class breeding program. This certification gives Aurora the exclusive rights to grow, propagate, and sell finished products produced from these varieties. The two protected cult
- SECSEC Form 6-K filed by Aurora Cannabis Inc.6-K - AURORA CANNABIS INC (0001683541) (Filer)
- PRAurora Advances Global Medical Cannabis Portfolio with New Product Launches Across Key International MarketsNASDAQ | TSX: ACBQ1 launches reinforce Aurora's medical‑first strategy, expanding access to high‑quality products across multiple formatsScaled launches across Canada, Europe and Australia support growing demand in regulated international medical marketsContinued focus on quality, patient needs and reliable global supply through Aurora's extensive GMP‑certified networkEDMONTON, AB, April 28, 2026 /CNW/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian‑based leading global medical cannabis company, is significantly expanding its global medical cannabis portfolio, with new product launches rolling out across Canada, Europe and Australia. The company continues to shape the global
- SECSEC Form 6-K filed by Aurora Cannabis Inc.6-K - AURORA CANNABIS INC (0001683541) (Filer)
- SECSEC Form 6-K filed by Aurora Cannabis Inc.6-K - AURORA CANNABIS INC (0001683541) (Filer)
- PRAurora Cannabis Accelerates Global Medical Cannabis Leadership with Accretive Acquisition of Safari Flower Company, Expanding EU GMP Capacity to Serve Growing High Margin International MarketsNASDAQ | TSX: ACBEDMONTON, AB, April 15, 2026 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, is pleased to announce it has acquired Safari Flower Company, an established EU GMP certified cannabis cultivator and manufacturer. Aggregate consideration is valued at $26.5 million, subject to customary adjustments, and inclusive of a cash payment of $2 million that is contingent on satisfaction of certain conditions (the "Transaction"). "The acquisition of Safari Flower Company marks an impor
- SECSEC Form 6-K filed by Aurora Cannabis Inc.6-K - AURORA CANNABIS INC (0001683541) (Filer)
- PRAurora Recognized for Executive Gender Diversity by the Globe & Mail for Second Consecutive YearNASDAQ | TSX: ACBThe Globe and Mail's Report on Business Women Lead Here List acknowledges Aurora's commitment to inclusive leadership at the executive levelEDMONTON, AB, March 30, 2026 /CNW/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian‑based leading global medical cannabis company, has been named on The Globe and Mail's 2026 Report on Business Women Lead Here list for the second consecutive year. The annual editorial benchmark recognizes publicly traded Canadian companies demonstrating strong executive‑level gender diversity, underscoring Aurora's continued commitment to inclusive leadership.
- PRAurora to Participate in the TD Cowen 46th Annual Health Care ConferenceNASDAQ | TSX: ACBCanada's Largest Global Medical Cannabis Company to Discuss Growth Strategy, Key Trends and Market OpportunitiesEDMONTON, AB, Feb. 17, 2026 /CNW/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, will participate in TD Cowen's 46th Annual Health Care Conference in Boston, MA. Simona King, Chief Financial Officer at Aurora, will take part in a fireside chat and one-on-one meetings with investors on March 2, 2026. Conference DetailsDATE: Monday, March 2, 2026TIME: 11:10am Eastern Time | 9:10am Mountain TimeW
- SECSEC Form 6-K filed by Aurora Cannabis Inc.6-K - AURORA CANNABIS INC (0001683541) (Filer)
- PRAurora to Ring the Nasdaq Closing Bell on Wednesday, February 18, 2026, Reinforcing Strategic Focus on Global Medical CannabisNASDAQ | TSX: ACB EDMONTON, AB, Feb. 12, 2026 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, announces the company will ring the Nasdaq closing bell on Wednesday, February 18, 2026, at the Nasdaq MarketSite in New York's Times Square. The ceremony will be led by Aurora's CEO and Executive Chairman, Miguel Martin, alongside a representative of the company's Board of Directors, executive leadership team and other employees. This e
- PRAurora Advances Global Medical Growth Strategy with Portfolio Expansion in Australia & New ZealandNASDAQ | TSX: ACB Launch reinforces Aurora's leadership position across key international markets EDMONTON, AB, Feb. 11, 2026 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, is expanding its Aurora® medical portfolio in Australia and New Zealand, delivering patients and prescribers enhanced choice, reliable quality, and easier access to science-backed products. The expansion underscores the company's ongoing dedication to meeting the unique needs of patients and healthcare professionals in the region, reflecting Aurora's strategic focus on long-term global growth.
- SECSEC Form 6-K filed by Aurora Cannabis Inc.6-K - AURORA CANNABIS INC (0001683541) (Filer)
- SECSEC Form 6-K filed by Aurora Cannabis Inc.6-K - AURORA CANNABIS INC (0001683541) (Filer)
- SECSEC Form 6-K filed by Aurora Cannabis Inc.6-K - AURORA CANNABIS INC (0001683541) (Filer)
- SECSEC Form SUPPL filed by Aurora Cannabis Inc.SUPPL - AURORA CANNABIS INC (0001683541) (Filer)
- SECSEC Form 6-K filed by Aurora Cannabis Inc.6-K - AURORA CANNABIS INC (0001683541) (Filer)
- PRAurora Cannabis Announces Filing of Prospectus Supplement for At-The-Market Offering ProgramNASDAQ | TSX: ACB EDMONTON, AB, Feb. 4, 2026 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian based leading global medical cannabis company, announced today that it has filed a prospectus supplement establishing a new at-the-market offering program (the "ATM Program") that allows the Company to issue and sell up to U.S.$100 million of common shares in the capital of the Company (the "Common Shares") from treasury to the public, from time to time, at the Company's discretion. The Company intends to use the net proceeds from th
- PRAurora Cannabis Announces Fiscal 2026 Third Quarter ResultsNASDAQ | TSX: ACB Expands YoY Total Net Revenue1 by 7% to $94.2 million, with Global Medical Cannabis Net Revenue1 Increasing by 12% to a Record $76.2 millionDelivers Adjusted EBITDA1 of $18.5 million and Adjusted Net Income1 of $7.2 millionGenerates Free Cash Flow1 of $15.5 million Maintains Strong Balance Sheet with $154.4 million of Cash2 and Short-Term Investments, and a Debt-Free Cannabis Business2EDMONTON, AB, Feb. 4, 2026 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the third quarter 2026 period ending December 31, 2025.
- PRAurora Launches New European Websites, Showcasing Science-Backed Cannabis LeadershipNASDAQ | TSX: ACB Launch of improved, localized websites underscores Aurora's long-term strategy for growth and engagement across key European medical markets EDMONTON, AB, Feb. 3, 2026 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, announces the launch of four brand new websites to support key European markets, continuing its investment in the region through a more focused, locally-relevant digital presence. The refreshed platforms are designed to better reflect Aurora's science-backed approach, manufacturing expertise, and brand strength, while improving engagement with healthcare professionals, partners, and prospect
ACB FAQ
6 questionsWhat does Aurora Cannabis Inc. do?
Aurora Cannabis Inc. produces and distributes medical cannabis products worldwide. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, including facility engineering and design, cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories, including valves, screens...Where does ACB stock trade?
Aurora Cannabis Inc. (ACB) is listed on NYSE.What sector and industry is ACB in?
Aurora Cannabis Inc. operates in the Health Care sector, Medicinal Chemicals and Botanical Products industry.What are analysts saying about ACB?
Aurora Cannabis Inc. has had 8 recent analyst actions on file. The most recent action was from Canaccord Genuity: Buy on 2026-01-27. Recent price targets range from $960.00 to $1075.00.What companies are similar to ACB?
Notable peers in the same industry include PM (Philip Morris International Inc), BTI (British American Tobacco Industries p.l.c.), MO (Altria Group Inc.), RGC (Regencell Bioscience Holdings Limited), RLX (RLX Technology Inc.). Compare ACB side-by-side with any of them on Quantisnow.How can I track ACB on Quantisnow?
Quantisnow aggregates Aurora Cannabis Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ACB to receive live email and push alerts on every new disclosure.